Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine

Acta Derm Venereol. 2015 May;95(5):602-3. doi: 10.2340/00015555-2002.

Authors

Valerie C Amann¹, Jil Dreier, Desislava Ignatova, Jivko Kamarashev, Katrin Kerl, Werner Kempf, Steve Pascolo, Reinhard Dummer, Antonio Cozzio, Emmanuella Guenova

Affiliation

¹ Department of Dermatology, University Hospital Zurich, Gloriastr. 31, Zurich, Switzerland.

PMID: 25366134
DOI: 10.2340/00015555-2002

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Antimalarials / administration & dosage
Biopsy, Needle
CD8 Antigens / immunology
Dose-Response Relationship, Drug
Drug Administration Schedule
Follow-Up Studies
Humans
Hydroxychloroquine / administration & dosage*
Immunohistochemistry
Lymphoma, Non-Hodgkin / diagnostic imaging
Lymphoma, Non-Hodgkin / drug therapy*
Lymphoma, Non-Hodgkin / pathology
Lymphoma, T-Cell, Cutaneous / diagnostic imaging
Lymphoma, T-Cell, Cutaneous / drug therapy*
Lymphoma, T-Cell, Cutaneous / pathology*
Male
Middle Aged
Neoplasm Invasiveness / pathology
Neoplasm Staging
Positron-Emission Tomography / methods
Skin Neoplasms / diagnostic imaging
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology*
Switzerland
Treatment Outcome

Substances

Antimalarials
CD8 Antigens
Hydroxychloroquine